Metraipolis › archive › dc_dc1beabb2dd4

Real-world data analysis of the risk of Fournier's gangrene in patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) — Europe PMC PMID:41451372

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41451372
DOI: 10.3389/fphar.2025.1643866
License (as archived): solo-consultazione
Archived: 2026-11-07T18:26:06.657Z
SHA-256 of the archived text: 29db816c60ce934317401ea9c42c572167b9e9feb8f75e13128aba9b9ddd2212
Stable URL of this page: https://metraipolis.com/documento/dc_dc1beabb2dd4

How to cite

Real-world data analysis of the risk of Fournier's gangrene in patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) — Europe PMC PMID:41451372 — Europe PMC (en), https://europepmc.org/article/MED/41451372 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc1beabb2dd4 (Metraipolis archive dc_dc1beabb2dd4, sha256 29db816c60ce934317401ea9c42c572167b9e9feb8f75e13128aba9b9ddd2212)

BibTeX

@misc{dcdc1beabb2dd4,
  title = {Real-world data analysis of the risk of Fournier's gangrene in patients using sodium-glucose cotransporter 2 inhibitors (SGLT2i) — Europe PMC PMID:41451372},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41451372},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc1beabb2dd4; sha256 29db816c60ce934317401ea9c42c572167b9e9feb8f75e13128aba9b9ddd2212},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41451372. Agents can read the archived copy with the MCP tool read_document.